Class A shared drug concept stocks rose, Saili Medical hit the daily limit, Rongchang Bio rose by more than 7%, Shutai God rose by more than 6%, Zhaoyan New Pharmaceutical and Hanyu Pharmaceutical rose one after another. On the news, the National Medical Insurance Administration and the National Health Commission issued the "Support for high-quality innovative drugs...
2025-07-01 01:38:17
Class A shared drug concept stocks rose, Saili Medical hit the daily limit, Rongchang Bio rose more than 7%, Shutai God rose more than 6%, Zhaoyan New Pharmaceutical and Hanyu Pharmaceutical rose one after another. On the news, the National Medical Insurance Administration and the National Health Commission issued "Several Measures to Support the High-quality Development of Innovative Drugs", which proposed to support medical insurance data for innovative drug research and development.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
